Description
The global biopreservation market is estimated to reach USD 2223.7 million by the end of 2016. Considering the current market status, growth indicator and expected future trends, the market is estimated to reach USD 3312.9 billion by 2021, growing at a CAGR of 8.3 % during the forecast period.
The global biopreservation market study report comprises of worldwide biopreservation market information such as market size, value, and forecasts. It offers an extensive analysis of every segment of the market in major regions across the globe. In addition to the market estimation, the report throws light on the competitive landscape, as well. Moreover, the study documents company profiles of all the major market players, comprising of their business strategy and SWOT analysis, etc. The key offerings and elaborative report structure are specified in the description that follows.
Purchase a copy of Global Biopreservation Market visit @ http:// www. orbisresearch. com / contact / purchase / 220494 For more information contact sales @ orbisresearch. com.
Market Dynamics: Drivers and Restraints Improving healthcare expenditure around the world, advancements in research and development, adoption of in-house sample storage in hospitals and labs, and investments in bio-banks and personalized medicine are some of the factors driving the market for biopreservation. However, the high cost of instruments and their maintenance and possibility of tissue injury during preservation and thawing are a few major restraining factors hindering the growth of the market.
Market Segmentation The global biopreservation market is segmented into: Type of Products End-User Application Services Geography
The product segment is further divided on the basis of biopreservation media( nutrient media, sera, and other supplements) and equipment( temperature maintaining units- freezers, cryogenic storage systems, thawing equipment, refrigerators, and centrifuges). The end-user segment is sub-segmented into biobanks, gene banks, and hospitals. The application segment is divided into therapeutics, research, clinical trials and others. Further, the market is also segmented into various services such as biobanking for individuals( umbilical cord / stem cell banking, ovum / egg banking), and biobanking for institutes( tissue banking, cell banking services, organ banking, and repository services).
Geographically, the market is segmented into North America( the USA, Canada and Mexico), Europe( Germany, the UK, France, Italy, Spain & Portugal, Scandinavia, BENELUX), Asia-Pacific( China, Japan, India, Australia and New Zealand, South Korea), the Middle East and Africa( GCC, South Africa) and Latin America( Brazil and Argentina). www. orbisresearch. com; + 1( 214) 884-6817; + 9120-64101019